Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation
Clinical trial NCT04415567 · COMPLETED
Trial details
- NCT number
- NCT04415567
- Sponsor
- Jinyang Gu
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-06-01
- Primary completion
- 2020-03-31
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.